Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease

BACKGROUND: Repressor element 1-silencing transcription (REST)/neuron-restrictive silencer factor is considered a new therapeutic target for neurodegenerative disorders such as Alzheimer’s disease (AD). However, the relationship between AD and REST remains unclear. This study aimed to 1) examine pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Mingqing, Ni, Jingnian, Shi, Jing, Li, Ting, Xu, Xiaoqing, Li, Chenmeng, Qin, Bin, Fan, Dongsheng, Xie, Hengge, Wang, Zhong, Wang, Yongyan, Lu, Tao, Tian, Jinzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158200/
https://www.ncbi.nlm.nih.gov/pubmed/35650520
http://dx.doi.org/10.1186/s12877-022-03163-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158200/
https://www.ncbi.nlm.nih.gov/pubmed/35650520
http://dx.doi.org/10.1186/s12877-022-03163-8

Ejemplares similares